Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis—Pilot study. Issue 1 (21st November 2022)

• Record Type: Journal Article
• Authors: Solarz, Paweł; Bodnar, Magdalena; Czech, Joanna; Mackiewicz–Nartowicz, Hanna; Sinkiewicz, Anna; Szylberg, Łukasz; Borowczak, Jędrzej; Rutkiewicz, Paula; Zwierz, Aleksander; Burduk, Paweł
• Is Part Of: Journal of medical virology. Volume 95:Issue 1(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-11-21
• Subjects: Cidofovir -- larynx -- papilloma; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.28303
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: Recurrent respiratory papillomatosis is strictly connected with human papillomavirus (HPV) infection of the epithelium of the upper respiratory tract. The main treatment of lesions located in the larynx or lower pharynx includes microsurgical excision by using a CO2 laser. To decrease the amount of surgical procedures gain in importance combined therapy with antiviral agents. The aim of this study was to investigate the effect of the intralesional application of Cidofovir on the tissue of laryngeal papillomas. We have shown that simultaneous microsurgery with adjuvant therapy of Cidofovir reduces chronic inflammation (by measuring the expression of CD4 and CD8 in tissue samples), cell proliferation, and regulates the cell cycle of HPV‐infected cells by reducing the expression of p53 and p63 proteins. In addition, this strategy reduces the multiple surgical procedures and regrowth of the pathology.